Nicholas Bandarenko

Author PubWeight™ 23.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010 3.47
2 Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS 2008 2.87
3 Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke 2004 1.78
4 Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007 1.38
5 A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients. Transfusion 2009 1.29
6 Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 2012 1.06
7 Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl 2009 1.00
8 Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol 2007 0.97
9 Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers. Transfusion 2012 0.92
10 A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery. Transfusion 2010 0.92
11 The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher 2007 0.83
12 Randomized study of washing 40- to 42-day-stored red blood cells. Transfusion 2014 0.81
13 Category IV indications for therapeutic apheresis: ASFA fourth special issue. J Clin Apher 2007 0.81
14 Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG). Biol Blood Marrow Transplant 2006 0.80
15 Platelet factor 4/heparin antibodies in blood bank donors. Am J Clin Pathol 2010 0.79
16 The relationship of plasma transfusion from female and male donors with outcome after cardiac surgery. J Thorac Cardiovasc Surg 2010 0.78
17 Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol 2013 0.77
18 Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease? Semin Thromb Hemost 2005 0.77
19 Many, but not all, outcome studies support exclusion of female plasma from the blood supply. Expert Rev Hematol 2010 0.76
20 Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Ther Apher Dial 2006 0.76
21 Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion. Transfusion 2013 0.75
22 Posttransfusion thrombocytopenia: a cautionary tale of female group AB plasma. Transfusion 2013 0.75
23 Update on multi-center clinical trials in the United States. Transfus Apher Sci 2007 0.75
24 How we approach an apheresis request for a Category III, Category IV, or noncategorized indication. Transfusion 2007 0.75